Our study is the first to show the protective role of Cx43 or the gap junction during the subacute phase after cerebral ischemia, which suggests that enhancing the expression of Cx43 or function of the gap junction can be a promising candidate to promote neurorehabilitation after cerebral ischemia. The gene discussed is GJA1; the disease is brain ischemia.